Cargando…

Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is often seen together with components of metabolic syndrome. The aim of this study was to assess the risk of de novo post-transplant type 2 diabetes (DM) in liver transplant recipients with NASH. METHODS: All adult patients from the Scientific Regist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stepanova, Maria, Henry, Linda, Garg, Rishi, Kalwaney, Shirley, Saab, Sammy, Younossi, Zobair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678589/ https://www.ncbi.nlm.nih.gov/pubmed/26666336 http://dx.doi.org/10.1186/s12876-015-0407-y

Ejemplares similares

Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients
por: Stepanova, Maria, et al.
Publicado: (2022)

Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
por: Golabi, Pegah, et al.
Publicado: (2018)

Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States
por: Siddique, Osama, et al.
Publicado: (2017)

Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
por: Stepanova, Maria, et al.
Publicado: (2017)

Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
por: Balitzer, Dana, et al.
Publicado: (2022)

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Younossi, Zobair M., et al.
Publicado: (2021)

De novo Hepatocellular Carcinoma after Liver Transplantation
por: Saab, Sammy, et al.
Publicado: (2015)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor
por: Stepanova, Maria, et al.
Publicado: (2016)

The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2016)

Nonalcoholic steatohepatitis: global impact and clinical consequences
por: Kabarra, Khaled, et al.
Publicado: (2021)

Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease
por: Sayiner, Mehmet, et al.
Publicado: (2016)

Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
por: Haldar, Debashis, et al.
Publicado: (2019)

Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis
por: Estep, Michael, et al.
Publicado: (2019)

Pediatric Non-Alcoholic Fatty Liver Disease
por: Bush, Haley, et al.
Publicado: (2017)

Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
por: Sayiner, Mehmet, et al.
Publicado: (2018)

COVID-19 in Liver Transplant Recipients
por: Kullar, Ravina, et al.
Publicado: (2021)

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
por: Golabi, Pegah, et al.
Publicado: (2018)

Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimens
por: Younossi, Zobair M., et al.
Publicado: (2016)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes
por: Younossi, Zobair, et al.
Publicado: (2022)

Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC
por: Younossi, Zobair M., et al.
Publicado: (2023)

Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care
por: Younossi, Zobair M., et al.
Publicado: (2016)

Trends in Liver Transplantation in Hepatitis C Virus–Infected Persons, United States
por: Perumpail, Ryan B., et al.
Publicado: (2016)

Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study
por: Younossi, Zobair M, et al.
Publicado: (2014)

Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2018)

De Novo Esophageal Carcinoma in Post-liver Transplant Patient
por: Tank, A. H., et al.
Publicado: (2014)

Post liver transplant recurrent and de novo viral infections
por: Jothimani, Dinesh, et al.
Publicado: (2020)

Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States
por: Paik, James M., et al.
Publicado: (2019)

Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing
por: Pellegrina, Diogo, et al.
Publicado: (2023)

The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019
por: Paik, James M., et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States
por: Paik, James M., et al.
Publicado: (2020)

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
por: Younossi, Zobair M., et al.
Publicado: (2021)

Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
por: Battistella, Sara, et al.
Publicado: (2023)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease
por: Mehta, Rohini, et al.
Publicado: (2016)

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C)
por: Birerdinc, Aybike, et al.
Publicado: (2012)

Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge
por: Steggerda, Justin A, et al.
Publicado: (2020)

Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation
por: Wu, Eric M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_me9kq3mlirb4tqkifigil49edp